about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
29.69
1.72
(6.15%)
781.3K
XNAS Volume
XNAS 09 Oct, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..